Nature: With labeling debate over, time to focus on more pressing biotech issues

Screen Shot at AM

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

[In early July], the US Senate passed a bill that will . . . create federal standards for GM labels. . . . Like many good solutions to complex problems, it leaves both sides in the debate feeling hard done by.

. . . .

But . . . quenching the labelling debate could open the door to discussions about more pressing matters. Vast resources — both time and money — have been poured into the labelling debate. There is an opportunity now to redirect those resources.

In June, the [EPA] determined that the agency was not doing enough to cope with the rise of insects resistant to the pesticide produced by some GM crops. . . . And sophisticated gene-editing technologies are helping to bring a new breed of engineered crops to market, yet regulators are still grappling with how to handle them.

Each of these issues is steeped in complex science, and researchers should seize every opportunity to inform — and encourage — discussions around them. . . .[M]any researchers are hesitant to enter the fray surrounding GM crops. But without their input, the discussion is unlikely to progress.

Read full, original post: Researchers and policymakers are now free to tackle the most-pressing GM issues

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-25-2026-01_14_50-PM
Viewpoint: Disinformation grift: The wellness industry is a lucrative and mostly worthless marketplace of ‘balms, brews, and baloney’
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jun-23-2026-12_19_35-PM
Ideological red flag: Led by anti-vax doctor, Tennessee is now the U.S. epicenter selling potent ivermectin shown worthless to prevent or treat Covid
Screenshot-2026-06-30-at-10.43.50-AM
Viewpoint: Why are there no approved bioengineered insect-protected (Bt) apples?
Screenshot-2026-06-05-at-2.12.30-PM
Some plants can poison you. So how did humans figure out what is safe to eat?
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Mar-4-2026-09_39_03-AM
Transgender female athletes and Title IX: Separating ‘policy’ from ‘legality’
marijuana-pot-in-hand-nveri-st-xpm-t-abq-fkifeos-s-rws-cmpx-
Facts & Fallacies podcast: Legalized weed drives drug addiction, psychosis?
ChatGPT-Image-Jun-22-2026-01_30_11-PM
Facts & Fallacies podcast: Psychedelics for PTSD? Examining RFK, Jr's claims about ibogaine

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.